The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Mendoza Maldonado, Ramiro ^a   Faoro, Valentina ^a,b   Bajpai, Sailesh ^a   Berti, Matteo ^a   Odreman, Federico ^a   Vindigni, Marco ^c   Ius, Tamara ^c   Ghasemian, Abdollah ^a,f   Bonin, Serena ^b   Skrap, Miran ^c   Stanta, Giorgio ^a,b   Vindigni, Alessandro ^a,d,e  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SINCROTRONE TRIESTE   (Italy)

^f SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GAMMA H2AX PROTEIN; HYDROXYUREA; RECQ HELICASE; RECQ1 HELICASE; TEMOZOLOMIDE; UNCLASSIFIED DRUG; RECQL PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN DEPLETION; PROTEIN EXPRESSION; THYROID CANCER; TISSUE MICROARRAY; TUMOR CELL; ANIMAL; BRAIN TUMOR; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR VOLUME; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MICE; MIDDLE AGED; RECQ HELICASES; RNA, SMALL INTERFERING; TUMOR BURDEN; UP-REGULATION;

EID: 79960111219     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-83     Document Type: Article

References (52)

1. Hickson ID. RecQ helicases: caretakers of the genome. Nat Rev Cancer 2003, 3:169-178. 10.1038/nrc1012, 12612652.
2. Opresko PL, Cheng WH, Bohr VA. Junction of RecQ helicase biochemistry and human disease. J Biol Chem 2004, 279:18099-18102. 10.1074/jbc.R300034200, 15023996.
3. Wu L, Hickson ID. DNA helicases required for homologous recombination and repair of damaged replication forks. Annu Rev Genet 2006, 40:279-306. 10.1146/annurev.genet.40.110405.090636, 16856806.
4. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M, German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995, 83:655-666. 10.1016/0092-8674(95)90105-1, 7585968.
5. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, et al. Positional cloning of the Werner's syndrome gene. Science 1996, 272:258-262. 10.1126/science.272.5259.258, 8602509.
6. Kitao S, Lindor NM, Shiratori M, Furuichi Y, Shimamoto A. Rothmund-thomson syndrome responsible gene, RECQL4: genomic structure and products. Genomics 1999, 61:268-276. 10.1006/geno.1999.5959, 10552928.
7. Siitonen HA, Kopra O, Kaariainen H, Haravuori H, Winter RM, Saamanen AM, Peltonen L, Kestila M. Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. Hum Mol Genet 2003, 12:2837-2844. 10.1093/hmg/ddg306, 12952869.
8. Van Maldergem L, Siitonen HA, Jalkh N, Chouery E, De Roy M, Delague V, Muenke M, Jabs EW, Cai J, Wang LL, et al. Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J Med Genet 2006, 43:148-152. 2564634, 15964893.
9. Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 2006, 24:1720-1728. 10.1200/JCO.2005.04.4206, 1435378, 16520463.
10. Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 2006, 66:3323-3330. 10.1158/0008-5472.CAN-05-3032, 1462866, 16540687.
11. Bachrati CZ, Hickson ID. RecQ helicases: guardian angels of the DNA replication fork. Chromosoma 2008, 117:219-233. 10.1007/s00412-007-0142-4, 18188578.
12. Vindigni A, Marino F, Gileadi O. Probing the structural basis of RecQ helicase function. Biophys Chem 2010, 149:67-77. 10.1016/j.bpc.2010.03.012, 20392558.
13. Bohr VA. Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem Sci 2008, 33:609-620. 10.1016/j.tibs.2008.09.003, 2606042, 18926708.
14. Ouyang KJ, Woo LL, Ellis NA. Homologous recombination and maintenance of genome integrity: cancer and aging through the prism of human RecQ helicases. Mech Ageing Dev 2008, 129:425-440. 10.1016/j.mad.2008.03.003, 18430459.
15. Sharma S, Doherty KM, Brosh RM. Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem J 2006, 398:319-337. 10.1042/BJ20060450, 1559444, 16925525.
16. Turley H, Wu L, Canamero M, Gatter KC, Hickson ID. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells. Br J Cancer 2001, 85:261-265. 10.1054/bjoc.2001.1874, 2364038, 11461087.
17. Opresko PL, Calvo JP, von Kobbe C. Role for the Werner syndrome protein in the promotion of tumor cell growth. Mech Ageing Dev 2007, 128:423-436. 10.1016/j.mad.2007.05.009, 17624410.
18. Arai A, Chano T, Futami K, Furuichi Y, Ikebuchi K, Inui T, Tameno H, Ochi Y, Shimada T, Hisa Y, Okabe H. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma. Cancer Res 2011,
19. Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto A, Furuichi Y. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Cancer Sci 2008, 99:71-80.
20. Futami K, Kumagai E, Makino H, Sato A, Takagi M, Shimamoto A, Furuichi Y. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci 2008, 99:1227-1236. 10.1111/j.1349-7006.2008.00794.x, 18422747.
21. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005, 23:2411-2422. 10.1200/JCO.2005.03.089, 15800333.
22. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459-466. 10.1016/S1470-2045(09)70025-7, 19269895.
23. Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007, 12:1395-1403. 10.1634/theoncologist.12-12-1395, 18165616.
24. Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 2007, 26:186-197. 10.1038/sj.onc.1209785, 16819506.
25. Cui S, Arosio D, Doherty KM, Brosh RM, Falaschi A, Vindigni A. Analysis of the unwinding activity of the dimeric RECQ1 helicase in the presence of human replication protein A. Nucleic Acids Res 2004, 32:2158-2170. 10.1093/nar/gkh540, 407823, 15096578.
26. Glavac DL, Nardon E. Methylation analysis in guidelines for molecular analysis in archive tissues 2011, Springer-Verlag GmbH, Germany.
27. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812. 10.1126/science.1164382, 2820389, 18772396.
28. Odreman F, Vindigni M, Gonzales ML, Niccolini B, Candiano G, Zanotti B, Skrap M, Pizzolitto S, Stanta G, Vindigni A. Proteomic studies on low- and high-grade human brain astrocytomas. J Proteome Res 2005, 4:698-708. 10.1021/pr0498180, 15952716.
29. Thangavel S, Mendoza-Maldonado R, Tissino E, Sidorova JM, Yin J, Wang W, Monnat RJ, Falaschi A, Vindigni A. Human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol Cell Biol 2010, 30:1382-1396. 10.1128/MCB.01290-09, 2832491, 20065033.
30. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319. 10.1038/nprot.2006.339, 17406473.
31. Marcello A, Ferrari A, Pellegrini V, Pegoraro G, Lusic M, Beltram F, Giacca M. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. Embo J 2003, 22:2156-2166. 10.1093/emboj/cdg205, 156077, 12727882.
32. Nikiforova MN, Hamilton RL. Molecular diagnostics of gliomas. Arch Pathol Lab Med 2011, 135:558-568.
33. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009, 360:765-773. 10.1056/NEJMoa0808710, 2820383, 19228619.
34. Brosh RM, Bohr VA. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res 2007, 35:7527-7544. 10.1093/nar/gkm1008, 2190726, 18006573.
35. Andreassen PR, Ho GP, D'Andrea AD. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 2006, 27:883-892.
36. Sharma S, Brosh RM. Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS One 2007, 2:e1297. 10.1371/journal.pone.0001297, 2111050, 18074021.
37. van Attikum H, Gasser SM. The histone code at DNA breaks: a guide to repair?. Nat Rev Mol Cell Biol 2005, 6:757-765. 10.1038/nrm1737, 16167054.
38. D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, Jiricny J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol 1998, 54:334-341.
39. Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL, Slack JA. NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 1994, 33:9045-9051. 10.1021/bi00197a003, 8049205.
40. Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma. Int J Mol Med 2010, 25:537-545.
41. Kawabe T, Tsuyama N, Kitao S, Nishikawa K, Shimamoto A, Shiratori M, Matsumoto T, Anno K, Sato T, Mitsui Y, et al. Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene 2000, 19:4764-4772. 10.1038/sj.onc.1203841, 11032027.
42. Popuri V, Bachrati CZ, Muzzolini L, Mosedale G, Costantini S, Giacomini E, Hickson ID, Vindigni A. The Human RecQ helicases, BLM and RECQ1, display distinct DNA substrate specificities. J Biol Chem 2008, 283:17766-17776. 10.1074/jbc.M709749200, 18448429.
43. Sharma S, Stumpo DJ, Balajee AS, Bock CB, Lansdorp PM, Brosh RM, Blackshear PJ. RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol 2007, 27:1784-1794. 10.1128/MCB.01620-06, 1820448, 17158923.
44. Chu WK, Hickson ID. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer 2009, 9:644-654. 10.1038/nrc2682, 19657341.
45. Wedge SR, Porteous JK, Newlands ES. 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. Br J Cancer 1996, 74:1030-1036. 10.1038/bjc.1996.485, 2077105, 8855970.
46. Kanzawa T, Germano IM, Kondo Y, Ito H, Kyo S, Kondo S. Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. Br J Cancer 2003, 89:922-929. 10.1038/sj.bjc.6601193, 2394478, 12942127.
47. Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol 2005, 27:481-488.
48. Guran S, Beyan C, Nevruz O, Yakicier C, Tunca Y. A chronic myeloid leukemia-like syndrome case with del (12) (p12) in a Li-Fraumeni syndrome family. Clin Lab Haematol 2005, 27:135-138. 10.1111/j.1365-2257.2005.00679.x, 15784129.
49. Montpetit A, Larose J, Boily G, Langlois S, Trudel N, Sinnett D. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia 2004, 18:1499-1504. 10.1038/sj.leu.2403441, 15284860.
50. Park J, Betel D, Gryfe R, Michalickova K, Di Nicola N, Gallinger S, Hogue CW, Redston M. Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites. Cancer Res 2002, 62:1284-1288.
51. Gupta R, Brosh RM. DNA repair helicases as targets for anti-cancer therapy. Curr Med Chem 2007, 14:503-517. 10.2174/092986707780059706, 17346143.
52. Sharma S, Doherty KM, Brosh RM. DNA helicases as targets for anti-cancer drugs. Curr Med Chem Anticancer Agents 2005, 5:183-199. 10.2174/1568011053765985, 15992349.